STOCK WATCH

PET pharmaceutical firm Animalcare was in the doghouse with investors after it dished out a profit warning.

In a trading update, the Aimlisted group said revenue was ‘slightly ahead of management expectations’ in 2017.

But it warned of margin pressure due to intense competition and a change in its sales mix. As a result, earnings are expected to be below market expectations in 2018, albeit ahead of the year before. Shares dived 21.9pc, or 58.5p, to 209p.